Chemical Reviews, volume 116, issue 2, pages 422-518
Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.
Yu Zhou
1
,
Jiang Wang
1
,
Zhanni Gu
1
,
Shuni Wang
1
,
Wei Zhu
1
,
José Luis Aceña
2, 3
,
Vadim A Soloshonok
2, 4
,
Kunisuke Izawa
5
,
Hong Liu
1
3
5
Hamari Chemicals
Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, Japan 533-0024
|
Publication type: Journal Article
Publication date: 2016-01-12
Journal:
Chemical Reviews
Quartile SCImago
Q1
Quartile WOS
Q1
SJR: 17.828
CiteScore: 106.0
Impact factor: 51.4
ISSN: 00092665, 15206890
General Chemistry
Abstract
Compounds Currently in Phase II−III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas Yu Zhou,† Jiang Wang,† Zhanni Gu,† Shuni Wang,† Wei Zhu,† Jose ́ Luis Aceña,*,‡,§ Vadim A. Soloshonok,*,‡,∥ Kunisuke Izawa,* and Hong Liu*,† †Key Laboratory of Receptor Research, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zu Chong Zhi Road, Shanghai 201203, China ‡Department of Organic Chemistry I, Faculty of Chemistry, University of the Basque Country UPV/EHU, Paseo Manuel Lardizab́al 3, 20018 San Sebastiań, Spain Department of Organic Chemistry, Autońoma University of Madrid, Cantoblanco, 28049 Madrid, Spain IKERBASQUE, Basque Foundation for Science, María Díaz de Haro 3, 48013 Bilbao, Spain Hamari Chemicals Ltd., 1-4-29 Kunijima, Higashi-Yodogawa-ku, Osaka, Japan 533-0024
Top-30
Journals
|
20
40
60
80
100
120
140
160
180
|
|
|
Organic Letters
177 publications, 7.97%
|
|
|
Journal of Organic Chemistry
172 publications, 7.74%
|
|
|
Angewandte Chemie - International Edition
109 publications, 4.91%
|
|
|
Angewandte Chemie
109 publications, 4.91%
|
|
|
European Journal of Organic Chemistry
96 publications, 4.32%
|
|
|
Organic and Biomolecular Chemistry
96 publications, 4.32%
|
|
|
Advanced Synthesis and Catalysis
95 publications, 4.28%
|
|
|
Journal of Fluorine Chemistry
88 publications, 3.96%
|
|
|
Chemical Communications
85 publications, 3.83%
|
|
|
Organic Chemistry Frontiers
83 publications, 3.74%
|
|
|
Chemistry - A European Journal
83 publications, 3.74%
|
|
|
ACS Catalysis
43 publications, 1.94%
|
|
|
Journal of the American Chemical Society
42 publications, 1.89%
|
|
|
Molecules
39 publications, 1.76%
|
|
|
Tetrahedron Letters
36 publications, 1.62%
|
|
|
Asian Journal of Organic Chemistry
36 publications, 1.62%
|
|
|
Beilstein Journal of Organic Chemistry
35 publications, 1.58%
|
|
|
Chemical Science
34 publications, 1.53%
|
|
|
Synthesis
32 publications, 1.44%
|
|
|
Tetrahedron
27 publications, 1.22%
|
|
|
RSC Advances
22 publications, 0.99%
|
|
|
Chemical Record
21 publications, 0.95%
|
|
|
ChemistrySelect
21 publications, 0.95%
|
|
|
Green Chemistry
19 publications, 0.86%
|
|
|
Chinese Chemical Letters
18 publications, 0.81%
|
|
|
Journal of Medicinal Chemistry
17 publications, 0.77%
|
|
|
Organic Process Research and Development
16 publications, 0.72%
|
|
|
Chinese Journal of Chemistry
16 publications, 0.72%
|
|
|
Synlett
14 publications, 0.63%
|
|
|
20
40
60
80
100
120
140
160
180
|
Publishers
|
100
200
300
400
500
600
700
|
|
|
Wiley
675 publications, 30.38%
|
|
|
American Chemical Society (ACS)
546 publications, 24.57%
|
|
|
Royal Society of Chemistry (RSC)
390 publications, 17.55%
|
|
|
Elsevier
291 publications, 13.1%
|
|
|
Springer Nature
78 publications, 3.51%
|
|
|
MDPI
62 publications, 2.79%
|
|
|
Georg Thieme Verlag KG
46 publications, 2.07%
|
|
|
Beilstein-Institut
35 publications, 1.58%
|
|
|
Taylor & Francis
15 publications, 0.68%
|
|
|
Pleiades Publishing
14 publications, 0.63%
|
|
|
Bentham Science Publishers Ltd.
8 publications, 0.36%
|
|
|
Oxford University Press
8 publications, 0.36%
|
|
|
Shanghai Institute of Organic Chemistry
8 publications, 0.36%
|
|
|
Frontiers Media S.A.
5 publications, 0.23%
|
|
|
Autonomous Non-profit Organization Editorial Board of the journal Uspekhi Khimii
3 publications, 0.14%
|
|
|
American Association for the Advancement of Science (AAAS)
3 publications, 0.14%
|
|
|
Canadian Science Publishing
2 publications, 0.09%
|
|
|
The Electrochemical Society of Japan
2 publications, 0.09%
|
|
|
Pharmaceutical Society of Japan
2 publications, 0.09%
|
|
|
Akademizdatcenter Nauka
2 publications, 0.09%
|
|
|
The Society of Synthetic Organic Chemistry, Japan
2 publications, 0.09%
|
|
|
Akademiai Kiado
2 publications, 0.09%
|
|
|
King Saud University
2 publications, 0.09%
|
|
|
Scientific Research Publishing
2 publications, 0.09%
|
|
|
American Society for Pharmacology and Experimental Therapeutics
1 publication, 0.05%
|
|
|
CSIRO Publishing
1 publication, 0.05%
|
|
|
Impact Journals
1 publication, 0.05%
|
|
|
International Union of Crystallography (IUCr)
1 publication, 0.05%
|
|
|
Public Library of Science (PLoS)
1 publication, 0.05%
|
|
|
100
200
300
400
500
600
700
|
- We do not take into account publications without a DOI.
- Statistics recalculated only for publications connected to researchers, organizations and labs registered on the platform.
- Statistics recalculated weekly.
Are you a researcher?
Create a profile to get free access to personal recommendations for colleagues and new articles.
Metrics
Cite this
GOST |
RIS |
BibTex |
MLA
Cite this
GOST
Copy
Zhou Yu. et al. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. // Chemical Reviews. 2016. Vol. 116. No. 2. pp. 422-518.
GOST all authors (up to 50)
Copy
Zhou Yu., Wang J., Gu Z., Wang S., Zhu W., Aceña J. L., Soloshonok V. A., Izawa K., Liu H. Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas. // Chemical Reviews. 2016. Vol. 116. No. 2. pp. 422-518.
Cite this
RIS
Copy
TY - JOUR
DO - 10.1021/acs.chemrev.5b00392
UR - https://doi.org/10.1021/acs.chemrev.5b00392
TI - Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.
T2 - Chemical Reviews
AU - Gu, Zhanni
AU - Wang, Shuni
AU - Aceña, José Luis
AU - Soloshonok, Vadim A
AU - Zhou, Yu
AU - Wang, Jiang
AU - Zhu, Wei
AU - Izawa, Kunisuke
AU - Liu, Hong
PY - 2016
DA - 2016/01/12
PB - American Chemical Society (ACS)
SP - 422-518
IS - 2
VL - 116
SN - 0009-2665
SN - 1520-6890
ER -
Cite this
BibTex
Copy
@article{2016_Zhou,
author = {Zhanni Gu and Shuni Wang and José Luis Aceña and Vadim A Soloshonok and Yu Zhou and Jiang Wang and Wei Zhu and Kunisuke Izawa and Hong Liu},
title = {Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas.},
journal = {Chemical Reviews},
year = {2016},
volume = {116},
publisher = {American Chemical Society (ACS)},
month = {jan},
url = {https://doi.org/10.1021/acs.chemrev.5b00392},
number = {2},
pages = {422--518},
doi = {10.1021/acs.chemrev.5b00392}
}
Cite this
MLA
Copy
Zhou, Yu., et al. “Next Generation of Fluorine-Containing Pharmaceuticals, Compounds Currently in Phase II-III Clinical Trials of Major Pharmaceutical Companies: New Structural Trends and Therapeutic Areas..” Chemical Reviews, vol. 116, no. 2, Jan. 2016, pp. 422-518. https://doi.org/10.1021/acs.chemrev.5b00392.